Table 1 Demographic and clinical characteristics of SLE and healthy controls
Characteristics | Healthy controls (n = 31) | SLE patients (n = 22) |
|---|---|---|
Age (years) | 42.29 ± 11.38 (24–62) | 36.29 ± 13.79 (13–71) |
Gender (female/male) | 27/4 | 20/2 |
Disease duration (years) | – | 6.5 ± 6.07 |
Renal diseases n (%) | – | 15 (68.1) |
Neurological disorder n (%) | – | 3 (13.6) |
Thrombocytopenia n (%) | – | 5 (22.7) |
Anti-ds-DNA antibody n (%) | – | 15 (68.1) |
IgG (mg/dL) | – | 1277 ± 388 |
IgM (mg/dL) | – | 81 ± 59 |
IgA (mg/dL) | – | 300 ± 128 |
SLEDAI | – | 6.27 ± 5.22 (2–20) |